Le Lézard
Classified in: Health, Business, Sports and recreation
Subject: SCZ

JMD Properties Presents The River Club for an Active Retirement


NEW YORK, June 13, 2019 /PRNewswire-PRWeb/ -- JMD Properties (OTC Markets: JMDP) is proud to present its signature property the River Club. The River Club is a boutique active adult community located in Tennessee's famed Cumberland Plateau region ? just 75 miles from Nashville.

The River Club is a gated community which features a clubhouse, pool, access to natural water features and much more. Within minutes of world class medical facilities and famous attractions such as Fall Creek Falls State Park, the community is the ideal retirement destination.

"The River Club is a growing community in a picturesque location," said Marissa Welner, CEO, "it's surrounded by abundant natural beauty and great recreational activities including 10 championship golf courses nearby."

The first phase of the River Club features 55 homesites, about two-thirds of which have been sold. The community features a range of homes on generously sized lots. JMD has already begun planning Phase II of the community.

About JMD Properties
JMDP focuses on several market spaces including multi-family, subdivision development and manufactured housing communities in burgeoning locations. Through careful market study and on the ground research the team at JMDP is able to discover opportunities in various markets that are often neglected by larger institutions. By combining entrepreneurial, legal, analytical, marketing and practical experience under one umbrella, JMDP has the ability to properly manage every aspect of a transaction from start to finish.

Safe?Harbor
Forward Looking Statements: This press release may include forward-looking statements. These forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by use of the words "believe," "expect," "intend," "anticipate," "estimate," "project," or similar expressions. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain and actual results may differ materially from those predicted in such forward-looking statements. Factors that could have a material adverse effect on the operations and future prospects of the Company include, but are not limited to, changes in interest rates; the economic health of the local real estate markets in which we operate; general economic conditions; legislative/regulatory changes; monetary and fiscal policies of the U.S. government, including policies of the U.S. Treasury and the Federal Reserve Board; competition; and changes in accounting principles, policies, and guidelines. These risks and uncertainties should be considered in evaluating forward-looking statements, and undue reliance should not be placed on such statements.

 

SOURCE JMD Properties Inc.


These press releases may also interest you

at 10:19
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...

at 10:17
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...

at 10:16
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...

at 10:15
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....



News published on and distributed by: